Pharmaceutical Raw Material Stabilization Guide
Step-by-step guide on processing and stabilizing APIs and excipients to ensure quality, compliance with GMP, and REACH regulations.
Photo: Shanjir H | Photo4life AU / Unsplash
Pharmaceutical raw materials, whether active pharmaceutical ingredients (APIs) or excipients, form the foundation of every medicinal product. Their proper processing and stabilization are crucial for maintaining the desired properties, such as efficacy, safety, and shelf life. Improper handling can lead to degradation, loss of efficacy, or even the formation of undesirable by-products. This article provides a practical guide on how to handle, store, and process these sensitive materials to meet quality requirements and regulatory standards, such as REACH and Good Manufacturing Practice (GMP).
1. Receiving and Quality Control of Pharmaceutical Raw Materials
The first and fundamental step in processing pharmaceutical raw materials is their thorough inspection upon receipt. Each delivery must be verified against the specifications listed in the delivery note and the Certificate of Analysis (CoA). The inspection includes a visual assessment of the packaging (integrity, cleanliness, labeling according to GHS/CLP), verification of the batch identification number, and comparison of physico-chemical parameters with pharmacopoeia requirements (e.g., European or USP). For sensitive substances, such as active pharmaceutical ingredients (APIs), it is also necessary to verify the transport conditions—temperature, humidity, and storage duration during transit.
In the laboratory, incoming analysis is performed according to standard methods, including determination of purity, moisture content, solubility, or the presence of impurities. For some raw materials (e.g., excipients such as lactose or microcrystalline cellulose), particle size and size distribution control are also crucial, as they affect the homogeneity of mixtures. All results are documented and compared with internal limits, which are stricter than pharmacopoeia requirements, to minimize the risk of deviations in later production stages.
2. Storage of Raw Materials: Conditions and Contamination Prevention
Proper storage of pharmaceutical raw materials is critical to maintaining their stability and efficacy. Raw materials must be stored in separate, controlled spaces with defined temperature, humidity, and lighting. For example, thermolabile substances (e.g., certain antibiotics or vaccines) require storage at temperatures of 2–8 °C, while hygroscopic materials (such as mannitol) need low relative humidity below 40%. The spaces must be equipped with a monitoring system that tracks conditions in real time and alerts to any deviations.
Preventing cross-contamination is another key aspect. Raw materials are stored in sealed containers, ideally in the original packaging from the supplier, which is designed for long-term stability. For sensitive substances, double packaging or an inert atmosphere (nitrogen, argon) is used. It is also important to separate raw materials according to their nature – for example, highly potent active pharmaceutical ingredients (HPAPI) are stored in dedicated areas with strict access control and a dispensing system that minimizes worker exposure.
Photo: Patrick Hendry / Unsplash
3. Processing of Raw Materials: Grinding, Mixing, and Granulation
Before actual processing, it is often necessary to prepare raw materials to meet requirements for particle size, homogeneity, or flowability. Grinding is performed using special mills (e.g., ball, knife, or jet mills), which allow achieving the desired fineness without material degradation. For temperature-sensitive substances, cooled mills or grinding in an inert atmosphere are used. After grinding, particle size distribution analysis is conducted, which affects subsequent mixing and tablet compression.
Mixing is a critical operation, especially for blends with a low API content, where it is necessary to ensure uniform distribution of the active ingredient in the excipient. Various types of mixers (e.g., rotary, planetary, or fluid) are used, with the choice depending on the properties of the raw materials (bulk density, cohesiveness). To improve flowability and homogeneity, glidants (e.g., magnesium stearate) or wetting agents are often added. Granulation, whether wet or dry, is used to enhance flow properties and prevent segregation of components during compression.
4. Stabilization and Packaging: Ensuring Long-Term Quality
Stabilization of pharmaceutical raw materials and finished blends is essential to maintain their efficacy and safety throughout their shelf life. For sensitive substances, stabilizers such as antioxidants (e.g., ascorbic acid), chelating agents (EDTA), or buffers that maintain optimal pH are used. For moisture-sensitive materials, desiccants (e.g., silica gel) are added, or they are packaged in waterproof containers with barrier properties.
Packaging must protect raw materials from environmental influences such as moisture, light, or oxygen. For solids, multi-layer films with an aluminum layer or containers with inert gas are often used. Liquids and semi-solid substances are packaged in glass or plastic containers with sealing closures. Each package must be labeled according to GHS/CLP requirements, including batch information, expiration date, and storage conditions. After packaging, a leak and integrity check is performed to ensure that no contamination or degradation occurs during distribution.
Photo: Ricardo Gomez Angel / Unsplash
5. Process Validation and Documentation: The Key to Repeatability and Regulatory Compliance
Validation of processing procedures is a necessary step to ensure consistent quality of pharmaceutical raw materials. Every production step – from milling to granulation – must be thoroughly documented and verified in accordance with Good Manufacturing Practice (GMP) principles. Validation includes the determination of critical parameters such as temperature, humidity, processing time, or mixing speed, and their systematic monitoring. For example, during the milling of active pharmaceutical ingredients (API), it is necessary to verify whether degradation of the active substance occurs due to heat or mechanical stress. Processes are validated through repeated tests, where compliance with predefined acceptance criteria is monitored.
Documentation plays a key role in validation. Each production batch must be accompanied by protocols containing detailed information on the raw materials used, machine settings, inspection results, and any deviations. These records serve not only for internal audits but also to demonstrate compliance with regulatory requirements such as the REACH regulation or the EU directive on medicinal products. It is recommended to use electronic documentation management systems that minimize the risk of errors and facilitate the retrieval of historical data. Validation is not a one-time event – processes must be regularly revalidated, especially when there are changes in raw materials, equipment, or procedures.
6. Microbiological Purity Control and Contamination Prevention
Microbiological purity of pharmaceutical raw materials is critical for the safety of final medicinal products. Contamination by bacteria, moulds, or endotoxins can lead to serious health risks for patients and the spoilage of entire production batches. Control begins upon receipt of raw materials, where microbiological tests are performed according to standard methods, such as the determination of the total aerobic microbial count (TAMC) and tests for specific pathogens like *E. coli* or *Salmonella*. For raw materials with a high risk of contamination, such as plant extracts or gelatin, extended testing is recommended, including the detection of moulds and yeasts.
Preventing contamination requires strict adherence to hygiene procedures at all stages of processing. Workspaces must be regularly disinfected and monitored using surface and air swabs. Employees must use protective equipment such as sterile gloves, masks, and protective clothing, and undergo training on hygiene procedures. For raw materials sensitive to microbial growth, such as carbohydrates or proteins, it is advisable to add preservatives or process them in a controlled environment with low humidity. It is also important to separate clean and unclean zones in the production area and use closed systems for handling raw materials.
7. Optimizing Packaging for Long-Term Stability and Logistics
Proper packaging of pharmaceutical raw materials is essential to maintain their quality during storage and transport. The choice of packaging material depends on the physicochemical properties of the raw material, such as its sensitivity to moisture, light, or oxygen. For hygroscopic substances, such as certain salts or sugars, packaging with barrier properties is used, such as multilayer films with an aluminum layer or containers with desiccants. For light-sensitive substances, such as vitamins or some APIs, opaque packaging or dark glass containers are suitable. It is also important to ensure that the packaging is compatible with the raw material and that no migration of substances from the packaging into the product occurs.
In addition to protection against external influences, packaging must also meet logistics and handling requirements. Packaging should be designed to minimize the risk of damage during transport, for example, by using reinforcements or absorbent materials. For high-value raw materials or those at risk of contamination, packaging with seals or tamper-evident indicators is recommended. Proper identification of packaging using labels with clear information on the raw material name, batch number, expiration date, and any special storage conditions is also important. For international transport, it is necessary to comply with regulations for the transport of dangerous goods, such as the ADR agreement for road transport or IATA regulations for air transport.
Need Expert Support?
Every pharmaceutical raw material requires an individual approach. GCG Group provides detailed technical and safety data sheets (SDS) for the supplied raw materials and advises on selecting optimal processing and storage conditions to ensure maximum stability and quality of your products. Contact us – or browse our catalogue of over 1,300 products right away.